{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:26Z","timestamp":1792784906342,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"French Society of Hematology SFH","id":[{"id":"https:\/\/ror.org\/0263nzc55","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"DOI":"10.1038\/s41435-026-00410-5","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:48:12Z","timestamp":1785844092000},"page":"530-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33\/ST2 signaling"],"prefix":"10.1038","volume":"27","author":[{"given":"Lucie","family":"Gelon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Roga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Nahoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Pasquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u00efs","family":"Prade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Dufrechou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Largeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Delabesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-1259","authenticated-orcid":false,"given":"Lionel","family":"Mourey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0489-9298","authenticated-orcid":false,"given":"Emma","family":"Lefran\u00e7ais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"410_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155891","volume":"156","author":"C Cayrol","year":"2022","unstructured":"Cayrol C, Girard J-P. Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine. Cytokine. 2022;156:155891.","journal-title":"Cytokine"},{"key":"410_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard J-P, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16:676\u201389.","journal-title":"Nat Rev Immunol"},{"key":"410_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard J-P. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev. 2018;281:154\u201368.","journal-title":"Immunol Rev"},{"key":"410_CR4","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","volume":"385","author":"ME Wechsler","year":"2021","unstructured":"Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma. N Engl J Med. 2021;385:1656\u201368.","journal-title":"N Engl J Med"},{"key":"410_CR5","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","volume":"9","author":"KF Rabe","year":"2021","unstructured":"Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, et al. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. Lancet Respir Med. 2021;9:1288\u201398.","journal-title":"Lancet Respir Med"},{"key":"410_CR6","doi-asserted-by":"publisher","first-page":"00249","DOI":"10.1183\/23120541.00249-2023","volume":"9","author":"T Wilkinson","year":"2023","unstructured":"Wilkinson T, De Soyza A, Carroll M, Chalmers JD, Crooks MG, Griffiths G, et al. A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2. ERJ Open Res. 2023;9:00249\u20132023.","journal-title":"ERJ Open Res"},{"key":"410_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","volume":"363","author":"MF Moffatt","year":"2010","unstructured":"Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363:1211\u201321.","journal-title":"N Engl J Med"},{"key":"410_CR8","first-page":"6277","volume":"23","author":"B-B Sun","year":"2019","unstructured":"Sun B-B, Ma L-J, Qi Y, Zhang G-J. Correlation of IL-33 gene polymorphism with chronic obstructive pulmonary disease. Eur Rev Med Pharm Sci. 2019;23:6277\u201382.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"410_CR9","doi-asserted-by":"publisher","first-page":"e62144","DOI":"10.1371\/journal.pone.0062144","volume":"8","author":"A Latiano","year":"2013","unstructured":"Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro TT, Bossa F, et al. Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS One. 2013;8:e62144.","journal-title":"PLoS One"},{"key":"410_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.589639","volume":"12","author":"M Pei","year":"2021","unstructured":"Pei M, Liu X, Yang P, Zhao C, Gao F, Qu Y, et al. Genetic association of interleukin 33\/ST2 polymorphisms with Behcet\u2019s Uveitis. Front Immunol. 2021;12:589639.","journal-title":"Front Immunol"},{"key":"410_CR11","doi-asserted-by":"publisher","first-page":"e1006659","DOI":"10.1371\/journal.pgen.1006659","volume":"13","author":"D Smith","year":"2017","unstructured":"Smith D, Helgason H, Sulem P, Bjornsdottir US, Lim AC, Sveinbjornsson G, et al. A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma. PLoS Genet. 2017;13:e1006659.","journal-title":"PLoS Genet"},{"key":"410_CR12","doi-asserted-by":"publisher","first-page":"e1006925","DOI":"10.1371\/journal.pgen.1006925","volume":"13","author":"A Mousas","year":"2017","unstructured":"Mousas A, Ntritsos G, Chen M-H, Song C, Huffman JE, Tzoulaki I, et al. Rare coding variants pinpoint genes that control human hematological traits. PLoS Genet. 2017;13:e1006925.","journal-title":"PLoS Genet"},{"key":"410_CR13","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/cea.14562","volume":"54","author":"MA Portelli","year":"2024","unstructured":"Portelli MA, Ketelaar ME, Bates S, Csomor E, Shaw D, Emsley J, et al. Epithelial interleukin-1 receptor-like-1 activation is contingent on interleukin-33 isoforms and asthma-related receptor variation. Clin Exp Allergy. 2024;54:984\u201395.","journal-title":"Clin Exp Allergy"},{"key":"410_CR14","doi-asserted-by":"publisher","first-page":"e132446","DOI":"10.1172\/jci.insight.132446","volume":"5","author":"MA Portelli","year":"2020","unstructured":"Portelli MA, Dijk FN, Ketelaar ME, Shrine N, Hankinson J, Bhaker S, et al. Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium. JCI Insight. 2020;5:e132446.","journal-title":"JCI Insight"},{"key":"410_CR15","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jaci.2014.10.028","volume":"135","author":"V Ramirez-Carrozzi","year":"2015","unstructured":"Ramirez-Carrozzi V, Dressen A, Lupardus P, Yaspan B, Pappu R. Functional analysis of protective IL1RL1 variants associated with asthma risk. J Allergy Clin Immunol. 2015;135:1080\u2013.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"410_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jaci.2009.09.007","volume":"125","author":"H Wu","year":"2010","unstructured":"Wu H, Romieu I, Shi M, Hancock DB, Li H, Sienra-Monge J-J, et al. Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. J Allergy Clin Immunol. 2010;125:321\u2013.e13.","journal-title":"J Allergy Clin Immunol"},{"key":"410_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2500\/ajra.2009.23.3303","volume":"23","author":"R Castano","year":"2009","unstructured":"Castano R, Boss\u00e9 Y, Endam LM, Desrosiers M. Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23:377\u201384.","journal-title":"Am J Rhinol Allergy"},{"key":"410_CR18","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1172\/JCI67119","volume":"123","author":"JE Ho","year":"2013","unstructured":"Ho JE, Chen W-Y, Chen M-H, Larson MG, McCabe EL, Cheng S, et al. Common genetic variation at the IL1RL1 locus regulates IL-33\/ST2 signaling. J Clin Invest. 2013;123:4208\u201318.","journal-title":"J Clin Invest"},{"key":"410_CR19","doi-asserted-by":"publisher","first-page":"2400005","DOI":"10.1183\/13993003.00005-2024","volume":"63","author":"AK Saikumar Jayalatha","year":"2024","unstructured":"Saikumar Jayalatha AK, Ketelaar ME, Hesse L, Badi YE, Zounemat-Kermani N, Brouwer S, et al. IL-33 induced gene expression in activated Th2 effector cells is dependent on IL-1RL1 haplotype and asthma status. Eur Respir J. 2024;63:2400005.","journal-title":"Eur Respir J"},{"key":"410_CR20","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.4049\/jimmunol.1400176","volume":"193","author":"J Kim","year":"2014","unstructured":"Kim J, Kim W, Le HT, Moon UJ, Tran VG, Kim HJ, et al. IL-33-induced hematopoietic stem and progenitor cell mobilization depends upon CCR2. J Immunol. 2014;193:3792\u2013802.","journal-title":"J Immunol"},{"key":"410_CR21","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.bbmt.2019.05.030","volume":"25","author":"C Alt","year":"2019","unstructured":"Alt C, Yuan S, Wu F, Stankovich B, Calaoagan J, Schopies S, et al. Long-acting IL-33 mobilizes high-quality hematopoietic stem and progenitor cells more efficiently than granulocyte colony-stimulating factor or AMD3100. Biol Blood Marrow Transpl. 2019;25:1475\u201385.","journal-title":"Biol Blood Marrow Transpl"},{"key":"410_CR22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200164","volume":"217","author":"JW Swann","year":"2020","unstructured":"Swann JW, Koneva LA, Regan-Komito D, Sansom SN, Powrie F, Griseri T. IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors. J Exp Med. 2020;217:e20200164.","journal-title":"J Exp Med"},{"key":"410_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.intimp.2015.06.035","volume":"28","author":"P-P Li","year":"2015","unstructured":"Li P-P, Zhang X-M, Yuan D, Liu X, Li Y, Shan N-N. Decreased expression of IL-33 in immune thrombocytopenia. Int Immunopharmacol. 2015;28:420\u20134.","journal-title":"Int Immunopharmacol"},{"key":"410_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.21037\/atm-20-4729","volume":"9","author":"Y Zhan","year":"2021","unstructured":"Zhan Y, Cheng L, Wu B, Ji L, Chen P, Li F, et al. Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia. Ann Transl Med. 2021;9:222.","journal-title":"Ann Transl Med"},{"key":"410_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4049\/jimmunol.1402057","volume":"194","author":"D Talabot-Ayer","year":"2015","unstructured":"Talabot-Ayer D, Martin P, Vesin C, Seemayer CA, Vigne S, Gabay C, et al. Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33\u2013overexpressing CMV\/IL33 mice. J Immunol. 2015;194:750\u201360.","journal-title":"J Immunol"},{"key":"410_CR26","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.jaci.2016.01.032","volume":"138","author":"T Takeda","year":"2016","unstructured":"Takeda T, Unno H, Morita H, Futamura K, Emi-Sugie M, Arae K, et al. Platelets constitutively express IL-33 protein and modulate eosinophilic airway inflammation. J Allergy Clin Immunol. 2016;138:1395\u2013.e6.","journal-title":"J Allergy Clin Immunol"},{"key":"410_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41385-019-0134-8","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal Immunol. 2019;12:679\u201390.","journal-title":"Mucosal Immunol"},{"key":"410_CR28","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood.2021013474","volume":"139","author":"Z Chen","year":"2022","unstructured":"Chen Z, Luo J, Li J, Kim G, Stewart A, Huang Y, et al. Intestinal IL-33 promotes platelet activity for neutrophil recruitment during acute inflammation. Blood. 2022;139:1878\u201391.","journal-title":"Blood"},{"key":"410_CR29","doi-asserted-by":"publisher","unstructured":"Pariser DN, Hilt ZT, Ture SK, Blick-Nitko SK, Looney MR, Cleary SJ, et al. Lung megakaryocytes are immune modulatory cells. J Clin Invest. 2021;131. https:\/\/doi.org\/10.1172\/jci137377.","DOI":"10.1172\/jci137377"},{"key":"410_CR30","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood.2021013450","volume":"139","author":"N Mende","year":"2022","unstructured":"Mende N, Bastos HP, Santoro A, Mahbubani KT, Ciaurro V, Calderbank EF, et al. Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans. Blood. 2022;139:3387\u2013401.","journal-title":"Blood"},{"key":"410_CR31","doi-asserted-by":"publisher","unstructured":"Livada AC, McGrath KE, Malloy MW, Li C, Ture SK, Kingsley PD, et al. Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models. J Clin Invest. 2024;134. https:\/\/doi.org\/10.1172\/jci181111.","DOI":"10.1172\/jci181111"},{"key":"410_CR32","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1182\/bloodadvances.2025018363","volume":"10","author":"L Gelon","year":"2026","unstructured":"Gelon L, Roga S, Gonzalez-de-Peredo A, Vidal E, Girard J-P, Severin S, et al. The alarmin interleukin-33 modulates platelet proteome, function, and biogenesis. Blood Adv. 2026;10:2333\u201348.","journal-title":"Blood Adv"},{"key":"410_CR33","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.str.2009.08.009","volume":"17","author":"A Lingel","year":"2009","unstructured":"Lingel A, Weiss TM, Niebuhr M, Pan B, Appleton BA, Wiesmann C, et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure. 2009;17:1398\u2013410.","journal-title":"Structure"},{"key":"410_CR34","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1073\/pnas.1308651110","volume":"110","author":"X Liu","year":"2013","unstructured":"Liu X, Hammel M, He Y, Tainer JA, Jeng U-S, Zhang L, et al. Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci USA. 2013;110:14918\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"410_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.immuni.2017.08.004","volume":"47","author":"S G\u00fcnther","year":"2017","unstructured":"G\u00fcnther S, Deredge D, Bowers AL, Luchini A, Bonsor DA, Beadenkopf R, et al. IL-1 family cytokines use distinct molecular mechanisms to signal through their shared co-receptor. Immunity. 2017;47:510\u2013.e4.","journal-title":"Immunity"},{"key":"410_CR36","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1073\/pnas.1003059107","volume":"107","author":"K Oboki","year":"2010","unstructured":"Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA. 2010;107:18581\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"410_CR37","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","volume":"188","author":"KR Bartemes","year":"2012","unstructured":"Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol. 2012;188:1503\u201313.","journal-title":"J Immunol"},{"key":"410_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jaci.2014.02.002","volume":"134","author":"RJ Snelgrove","year":"2014","unstructured":"Snelgrove RJ, Gregory LG, Peir\u00f3 T, Akthar S, Campbell GA, Walker SA, et al. Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol. 2014;134:583\u2013.e6.","journal-title":"J Allergy Clin Immunol"},{"key":"410_CR39","doi-asserted-by":"publisher","first-page":"15502","DOI":"10.1073\/pnas.1410700111","volume":"111","author":"E Lefran\u00e7ais","year":"2014","unstructured":"Lefran\u00e7ais E, Duval A, Mirey E, Roga S, Espinosa E, Cayrol C, et al. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci USA. 2014;111:15502\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"410_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493\u2013500.","journal-title":"Nature"},{"key":"410_CR41","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1107\/S2052252524007693","volume":"11","author":"A Bhatt","year":"2024","unstructured":"Bhatt A, Mishra BP, Gu W, Sorbello M, Xu H, Ve T, et al. Structural characterization of TIR-domain signalosomes through a combination of structural biology approaches. IUCrJ. 2024;11:695\u2013707.","journal-title":"IUCrJ"},{"key":"410_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41594-021-00714-2","volume":"29","author":"GR Buel","year":"2022","unstructured":"Buel GR, Walters KJ. Can AlphaFold2 predict the impact of missense mutations on structure? Nat Struct Mol Biol. 2022;29:1\u20132.","journal-title":"Nat Struct Mol Biol"},{"key":"410_CR43","doi-asserted-by":"publisher","first-page":"e0282689","DOI":"10.1371\/journal.pone.0282689","volume":"18","author":"MA Pak","year":"2023","unstructured":"Pak MA, Markhieva KA, Novikova MS, Petrov DS, Vorobyev IS, Maksimova ES, et al. Using AlphaFold to predict the impact of single mutations on protein stability and function. PLoS One. 2023;18:e0282689.","journal-title":"PLoS One"},{"key":"410_CR44","doi-asserted-by":"publisher","first-page":"W122","DOI":"10.1093\/nar\/gkad472","volume":"51","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Pan Q, Pires DEV, Rodrigues CHM, Ascher DB. DDMut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res. 2023;51:W122\u2013W128.","journal-title":"Nucleic Acids Res"},{"key":"410_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00011-019-01307-y","volume":"69","author":"GI Yu","year":"2020","unstructured":"Yu GI, Song DK, Shin DH. Associations of IL1RAP and IL1RL1 gene polymorphisms with obesity and inflammation mediators. Inflamm Res. 2020;69:191\u2013202.","journal-title":"Inflamm Res"},{"key":"410_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2026.2639673","volume":"18","author":"J Chen","year":"2026","unstructured":"Chen J, Wang Y, Wang X. Structures of clinical antibodies bound to IL-33 uncover two distinct epitopes underlying differential efficacy. MAbs. 2026;18:2639673.","journal-title":"MAbs"},{"key":"410_CR47","doi-asserted-by":"publisher","first-page":"2202210","DOI":"10.1183\/13993003.02210-2022","volume":"62","author":"S Strickson","year":"2023","unstructured":"Strickson S, Houslay KF, Negri VA, Ohne Y, Ottosson T, Dodd RB, et al. Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE\/EGFR signalling complex. Eur Respir J. 2023;62:2202210.","journal-title":"Eur Respir J"},{"key":"410_CR48","first-page":"1","volume":"79","author":"A Sultana","year":"2015","unstructured":"Sultana A, Lee JE. Measuring protein-protein and protein-nucleic acid interactions by biolayer interferometry. Curr Protoc Protein Sci. 2015;79:1\u201319.","journal-title":"Curr Protoc Protein Sci"},{"key":"410_CR49","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1107\/S0907444904026460","volume":"60","author":"E Krissinel","year":"2004","unstructured":"Krissinel E, Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr. 2004;60:2256\u201368.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"410_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1107\/S2059798323003595","volume":"79","author":"J Agirre","year":"2023","unstructured":"Agirre J, Atanasova M, Bagdonas H, Ballard CB, Basl\u00e9 A, Beilsten-Edmands J, et al. The CCP4 suite: integrative software for macromolecular crystallography. Acta Crystallogr D Struct Biol. 2023;79:449\u201361.","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"410_CR51","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/bip.360221211","volume":"22","author":"W Kabsch","year":"1983","unstructured":"Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983;22:2577\u2013637.","journal-title":"Biopolymers"},{"key":"410_CR52","doi-asserted-by":"publisher","first-page":"D364","DOI":"10.1093\/nar\/gku1028","volume":"43","author":"WG Touw","year":"2015","unstructured":"Touw WG, Baakman C, Black J, te Beek TAH, Krieger E, Joosten RP, et al. A series of PDB-related databanks for everyday needs. Nucleic Acids Res. 2015;43:D364\u2013368.","journal-title":"Nucleic Acids Res"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00410-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:50:47Z","timestamp":1791863447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-026-00410-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1038\/s41435-026-00410-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8612877\/v1","asserted-by":"object"}]},"ISSN":["1476-5470"],"issn-type":[{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}